JPWO2023156453A5 - - Google Patents
Info
- Publication number
- JPWO2023156453A5 JPWO2023156453A5 JP2024547667A JP2024547667A JPWO2023156453A5 JP WO2023156453 A5 JPWO2023156453 A5 JP WO2023156453A5 JP 2024547667 A JP2024547667 A JP 2024547667A JP 2024547667 A JP2024547667 A JP 2024547667A JP WO2023156453 A5 JPWO2023156453 A5 JP WO2023156453A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- deuterium
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263268024P | 2022-02-15 | 2022-02-15 | |
| US202263268020P | 2022-02-15 | 2022-02-15 | |
| US63/268,024 | 2022-02-15 | ||
| US63/268,020 | 2022-02-15 | ||
| PCT/EP2023/053752 WO2023156453A1 (en) | 2022-02-15 | 2023-02-15 | Phenethylamine derivatives, compositions, and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025505745A JP2025505745A (ja) | 2025-02-28 |
| JP2025505745A5 JP2025505745A5 (https=) | 2026-02-24 |
| JPWO2023156453A5 true JPWO2023156453A5 (https=) | 2026-02-24 |
Family
ID=85278142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547667A Pending JP2025505745A (ja) | 2022-02-15 | 2023-02-15 | フェネチルアミン誘導体、組成物、及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250145566A1 (https=) |
| EP (1) | EP4479372A1 (https=) |
| JP (1) | JP2025505745A (https=) |
| KR (1) | KR20240153567A (https=) |
| AU (1) | AU2023222126A1 (https=) |
| CA (1) | CA3244130A1 (https=) |
| WO (1) | WO2023156453A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12122741B2 (en) | 2020-08-18 | 2024-10-22 | Cybin Irl Limited | Therapeutic phenethylamine compositions and methods of use |
| CA3209813A1 (en) | 2021-07-14 | 2023-01-19 | Mydecine Innovations Group Inc. | Novel short-acting psychoactive compounds of the mdma class |
| CA3218730A1 (en) * | 2022-02-28 | 2023-08-31 | Denton W. Hoyer | Novel prodrug compounds of 3,4-methylenedioxymethamphetamine (mdma) and methods of synthesizing the same |
| WO2024056678A1 (en) * | 2022-09-12 | 2024-03-21 | Mihkal Gmbh | Novel nootropic prodrugs of phenethylamine |
| WO2025228547A1 (en) * | 2024-05-01 | 2025-11-06 | Cybin Irl Limited | Processes for preparing phenethylamine compounds |
| US20250353808A1 (en) * | 2024-05-17 | 2025-11-20 | 2A Biosciences, Inc. | 5-methoxymethyl and 5-hydroxymethyl phenethylamines |
| CN120501709B (zh) * | 2025-06-03 | 2025-12-12 | 暨南大学 | 硫酸多黏菌素b干粉、吸入粉雾剂及其制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| ID28302A (id) | 1999-01-14 | 2001-05-10 | Teijin Ltd | Alat untuk mengumpankan suatu bubuk dalam jumlah tertentu |
| GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
| NZ514442A (en) | 1999-03-03 | 2003-08-29 | Optinose As | Nasal delivery device |
| GB0019715D0 (en) | 2000-08-10 | 2000-09-27 | Pa Consulting Services | Device for delivering physiologically active agent in powdered form |
| ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
| JP4795637B2 (ja) | 2001-09-28 | 2011-10-19 | カーブ テクノロジー，インコーポレイティド | 鼻ネブライザー |
| GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
| GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| WO2008016677A2 (en) * | 2006-08-02 | 2008-02-07 | Auspex Pharmaceuticals, Inc. | Preparation and utility of deuterated amphetamines |
| CN112430187B (zh) * | 2019-08-07 | 2023-01-17 | 北京奇点势能科技有限公司 | 一种α,β-氘代胺类化合物、氘代药物及其制备方法 |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
-
2023
- 2023-02-15 CA CA3244130A patent/CA3244130A1/en active Pending
- 2023-02-15 WO PCT/EP2023/053752 patent/WO2023156453A1/en not_active Ceased
- 2023-02-15 US US18/730,423 patent/US20250145566A1/en active Pending
- 2023-02-15 EP EP23705530.6A patent/EP4479372A1/en active Pending
- 2023-02-15 AU AU2023222126A patent/AU2023222126A1/en active Pending
- 2023-02-15 JP JP2024547667A patent/JP2025505745A/ja active Pending
- 2023-02-15 KR KR1020247028843A patent/KR20240153567A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519267A5 (https=) | ||
| ES2275758T3 (es) | Compuestos de isoindol-imida, sus composiciones y sus usos. | |
| IL297492A (en) | Deuterated tryptamine derivatives and methods of use | |
| JP2007508360A5 (https=) | ||
| JP2023009114A (ja) | エチホキシンの重水素化類似体、それらの誘導体、およびそれらの使用 | |
| JPWO2020245133A5 (https=) | ||
| JPWO2023156453A5 (https=) | ||
| CN103249697A (zh) | 适用作多巴胺能稳定剂的普利多匹定(pridopidine)氘化类似物 | |
| JP2006143749A5 (https=) | ||
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| JP2007530694A5 (https=) | ||
| JPWO2020198466A5 (https=) | ||
| JPWO2022038170A5 (https=) | ||
| JP2017512211A (ja) | アミノカルボニルカルバメート化合物 | |
| JPWO2021030555A5 (https=) | ||
| JPWO2019183341A5 (https=) | ||
| JPWO2022038171A5 (https=) | ||
| JP2007510741A5 (https=) | ||
| JPWO2022243285A5 (https=) | ||
| JPWO2023036473A5 (https=) | ||
| JP2017525684A5 (https=) | ||
| JPWO2020119819A5 (https=) | ||
| JPWO2023156450A5 (https=) | ||
| KR20100127279A (ko) | 2-아미노-2-[2-(4-ｃ3-ｃ21-알킬-페닐)에틸]프로판-1,3-디올의 제조 방법 | |
| JPWO2020247445A5 (https=) |